The Summit’s first season finale on Dec. 4 saw three remaining trekkers making it to the top of the Summit, including Punkin ...
While Summit's decision to end development is bad news for Sarepta, the biotech is on a good path for success in DMD field with the last week’s results of AAVrh74.MHCK7.micro-Dystrophin trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results